首页>
外国专利>
Combination therapy comprising ribavirin and interferon alpha in a patient without chronic antiviral treatment with chronic hepatitis C infection
Combination therapy comprising ribavirin and interferon alpha in a patient without chronic antiviral treatment with chronic hepatitis C infection
Use of ribavirin and interferon alpha to prepare pharmaceutical compositions for treating antiviral treatment naive patient having chronic hepatitis C infection to eradicate detectable HCV-RNA involving a combination therapy using a therapeutically effective amount of ribavirin and a therapeutically effective amount of interferon-alpha for a time period of from 20 up to 50 weeks are disclosed.
展开▼